The Resurgence of Exogenous Psychosis: A Phenomenological Examination of Substance-Induced Psychopathology.
Journal
The Journal of nervous and mental disease
ISSN: 1539-736X
Titre abrégé: J Nerv Ment Dis
Pays: United States
ID NLM: 0375402
Informations de publication
Date de publication:
01 Sep 2024
01 Sep 2024
Historique:
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
ppublish
Résumé
The psychopathological manifestations associated with substance use, including induced psychotic experiences, are increasingly relevant but not well-understood within the medical community. Novel psychoactive substances and potentiated old compounds like cannabis and cocaine have emerged as a global concern, especially among adolescents and young adults. Transition rates from substance-induced psychosis (SIP) to persistent psychosis are significant, particularly in cases of cannabis-induced psychosis. Scientific inquiry into induced psychotic phenomena has revealed differences between SIP and primary psychotic disorders, highlighting the risk factors associated with each. The concept of exogenous psychosis, including its toxic variant known as lysergic psychoma, provides valuable insights into the role of external factors in psychosis development. A phenomenological approach characterizes this disruption in perception as a shift in temporal and spatial dimensions, leading to auditory and visual hallucinations. The "twilight state" of consciousness plays a crucial role in the transition from substance use to psychosis, with implications for spatiality, intersubjectivity, and temporality. This complex path to psychosis challenges traditional diagnostic models and underscores the need for a more nuanced understanding of substance-induced psychopathological experiences.
Identifiants
pubmed: 39207290
doi: 10.1097/NMD.0000000000001800
pii: 00005053-202409000-00001
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
457-459Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Références
Angrist BM, Gershon S (1970) The phenomenology of experimentally induced amphetamine psychosis—preliminary observations. Biol Psychiatry. 2:95–107.
Bleuler E (1911) Dementia praecox or the group of schizophrenias. New York: International Universities Press.
Bonhoeffer K (1897) Der Geisteszustand des Alkoholdeliranten. In Psychiatrische Abhandlungen Wernicke. Breslau, Poland: Schletter.
Caton CLM, Drake RE, Hasin DS, Dominguez B, Shrout PE, Samet S (2005) Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch Gen Psychiatry. 62:137–145.
Chiappini S, Mosca A, Miuli A, Santovito MC, Orsolini L, Corkery JM, Guirguis A, Pettorruso M, Martinotti G, Di Giannantonio M, Schifano F (2021) New psychoactive substances and suicidality: A systematic review of the current literature. Medicina (Kaunas). 57:580.
Corazza O, Valeriani G, Bersani FS, et al. (2014) "Spice," "kryptonite," "black mamba": An overview of brand names and marketing strategies of novel psychoactive substances on the web. J Psychoactive Drugs. 46:287–294.
Crebbin K, Mitford E, Paxton R, Turkington D (2009) First-episode drug-induced psychosis: A medium term follow up study reveals a high-risk group. Soc Psychiatry Psychiatr Epidemiol. 44:710–715.
De Clerambault G (1994) Automatismo mentale-Psicosi passionali. Milan, Italy: Metis, Soteria.
Di Petta G, Tittarelli D (2016) Le psicosi sintetiche. Il contributo della psicopatologia fenomenologica italiana alle psicosi indotte da sostanze. Rome, Italy: Giovanni Fioriti Editore.
Di Petta G, Tittarelli D (2019) The "we-ness": A Dasein-analytical approach to group therapy. Psychopathology. 52:110–116.
Drake RE, Caton CL, Xie H, Hsu E, Gorroochurn P, Samet S, Hasin DS (2011) A prospective 2-year study of emergency department patients with early-phase primary psychosis or substance-induced psychosis. Am J Psychiatry. 168:742–748.
Hines LA, Freeman TP, Gage SH, Zammit S, Hickman M, Cannon M, Munafo M, MacLeod J, Heron J (2020) Association of high-potency cannabis use with mental health and substance use in adolescence. JAMA Psychiatry. 77:1044–1051.
Khokhar JY, Dwiel LL, Henricks AM, Doucette WT, Green AI (2018) The link between schizophrenia and substance use disorder: A unifying hypothesis. Schizophr Res. 194:78–85.
Klosterkötter J (2009) Früherkennung und Frühbehandlung von Psychosen [Early recognition and prevention of psychoses] [In German]. Fortschr Neurol Psychiatr. 77:431.
Martinotti G, De Risio L, Vannini C, Schifano F, Pettorruso M, Di Giannantonio M (2021) Substance-related exogenous psychosis: A postmodern syndrome. CNS Spectr. 26:84–91.
Mathias S, Lubman DI, Hides L (2008) Substance-induced psychosis: A diagnostic conundrum. J Clin Psychiatry. 69:358–367.
Messas G (2021) Plea for using dialectical phenomenological psychopathology as an approach for substance-use disorders. Clin Neuropsychiatry. 18:185–187.
Murrie B, Lappin J, Large M, Sara G (2020) Transition of substance-induced, brief, and atypical psychoses to schizophrenia: A systematic review and meta-analysis. Schizophr Bull. 46:505–516.
Ricci V, Ceci F, Di Carlo F, Di Muzio I, Ciavoni L, Santangelo M, Di Salvo G, Pettorruso M, Martinotti G, Maina G (2023) First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness. Psychiatry research. 320:115053.
Rognli EB, Heiberg IH, Jacobsen BK, Høye A, Bramness JG (2023) Transition from substance-induced psychosis to schizophrenia spectrum disorder or bipolar disorder. Am J Psychiatry. 180:437–444.
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature. 511:421–427.
Wearne TA, Cornish JL (2018) A comparison of methamphetamine-induced psychosis and schizophrenia: A review of positive, negative, and cognitive symptomatology. Frontiers in psychiatry. 9:491.